Skip to content

Clinical trials

Phase 2 Neuralgia, Postherpetic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia, Postherpetic Phase: Phase 2 Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20031
20043
20052
20062
20076
20088
20096
20105
20113
20124
20133
20142
20153
20161
20171
20191
20201
20222
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Terminated11
Unknown status4
Recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
UCB Pharma4
Allergan3
NeurogesX3
Merck Sharp & Dohme LLC2
Winston Laboratories2
XenoPort, Inc.2
Aestus Therapeutics1
Astellas Pharma Europe B.V.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia, Postherpetic63
Neuralgia21
Herpes Zoster16
Pain14
Peripheral Nervous System Diseases4
Chickenpox3
Diabetic Neuropathies3
Agnosia2
Hyperalgesia2
Peripheral Nerve Injuries2

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.